Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for ChemoCentryx, Inc. (CCXI)

« Back to company index

CCXI Chatter Timeline

Stock Ticker for CCXI

Most Active Tweeters for CCXI

UserTweets
@AmericanBanking 5
@bulletin_en 4
@TranscriptDaily 3
@SleekMoneycom 2
@stocknewstimes 2

Recent Tweets for CCXI

AmericanBanking @AmericanBanking
ChemoCentryx Inc $CCXI Receives Average Recommendation of “Buy” from Brokerages https://t.co/FOoxXZhG83 #stocks
May 23rd 2019, 9:05am
dailypoliticaln @dailypoliticaln
ChemoCentryx Inc $CCXI Given Average Rating of “Buy” by Analysts https://t.co/4c1vO1JEaG
May 23rd 2019, 9:05am
RVH_Investing @RVH_Investing
@DeepSouthDoctor Be careful on $AUPH. $CCXI I liked at first, but I couldn’t handle the CEO
May 23rd 2019, 7:05am
dispatchtribune @dispatchtribune
ChemoCentryx $CCXI Downgraded by ValuEngine to Buy https://t.co/bBTIRCccDG
May 23rd 2019, 5:05am
TheNoctrader @TheNoctrader
$CCXI if you can look past the choppy price movement I see a descending wedge forming that will find a support abov… https://t.co/jLYTHFZs5R
May 23rd 2019, 1:05am
ThisLincolnian @ThisLincolnian
ChemoCentryx Inc $CCXI Expected to Announce Quarterly Sales of $10.08 Million https://t.co/VG0Hn202UD
May 22nd 2019, 8:05am
TranscriptDaily @TranscriptDaily
ChemoCentryx $CCXI Downgraded by ValuEngine https://t.co/ii0ht6n6IP
May 22nd 2019, 2:05am
WatchlistN @WatchlistN
ChemoCentryx $CCXI Stock Rating Lowered by ValuEngine https://t.co/ftdsmKrWmr
May 21st 2019, 7:05am
TranscriptDaily @TranscriptDaily
ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/oc2XOPp8lQ
May 21st 2019, 4:05am
stocknewstimes @stocknewstimes
ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/J7S183Zgny
May 21st 2019, 4:05am
SleekMoneycom @SleekMoneycom
ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/LDZE9cvIrd #investing
May 21st 2019, 4:05am
TheMarketsDaily @TheMarketsDaily
ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/ZqALsDwA76
May 21st 2019, 4:05am
dailypoliticaln @dailypoliticaln
ChemoCentryx $CCXI Rating Lowered to Buy at ValuEngine https://t.co/UESmElJ3aI
May 21st 2019, 12:05am
SwingTradeIdeas @SwingTradeIdeas
$CCXI - ChemoCentryx (CCXI) Moves to Buy: Rationale Behind the Upgrade https://t.co/e9ahsRUxRv
May 20th 2019, 10:05am
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $CCXI for you: 17.68% https://t.co/UWhwbtw53i
May 20th 2019, 7:05am
Allstocknews @Allstocknews
$CCXI New Form EFFECT for ChemoCentryx, Inc. From our Stock News Alerts App
May 20th 2019, 6:05am
TheMarketsDaily @TheMarketsDaily
ChemoCentryx $CCXI Upgraded at Zacks Investment Research https://t.co/TRNFzpSzio
May 19th 2019, 9:05am
dakotafinancial @dakotafinancial
ChemoCentryx $CCXI Upgraded at Zacks Investment Research https://t.co/xQzZybT8lA
May 19th 2019, 9:05am
OlympiaReport @OlympiaReport
Analysts Anticipate ChemoCentryx Inc $CCXI Will Announce Quarterly Sales of $10.08 Million https://t.co/xiZh7Cr9Jc
May 19th 2019, 5:05am
AmericanBanking @AmericanBanking
Analysts Anticipate ChemoCentryx Inc $CCXI Will Post Quarterly Sales of $10.08 Million https://t.co/ZL5057T6fR #stocks
May 19th 2019, 5:05am
ZolmaxNews @ZolmaxNews
ChemoCentryx $CCXI Cut to Hold at Zacks Investment Research https://t.co/QMkHxlv7m3
May 19th 2019, 5:05am
TickerReport @TickerReport
B. Riley Brokers Boost Earnings Estimates for ChemoCentryx Inc $CCXI https://t.co/gpxVndFC4i
May 19th 2019, 1:05am
EnterpriseLeade @EnterpriseLeade
ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/hyeqRrMTUH
May 18th 2019, 12:05pm
registrarjourn @registrarjourn
ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/SB1bIahNuc
May 18th 2019, 12:05pm
stocknewstimes @stocknewstimes
ChemoCentryx $CCXI Upgraded by Zacks Investment Research to Buy https://t.co/ffqctIaH8p
May 18th 2019, 11:05am
SleekMoneycom @SleekMoneycom
ChemoCentryx $CCXI Upgraded by Zacks Investment Research to Buy https://t.co/5baahRRhlk #investing
May 18th 2019, 11:05am
bbnsnews @bbnsnews
B. Riley Weighs in on ChemoCentryx Inc’s FY2023 Earnings $CCXI https://t.co/Ort86bpe2E
May 18th 2019, 5:05am
WKRBNews @WKRBNews
Q2 2019 EPS Estimates for ChemoCentryx Inc Raised by B. Riley $CCXI https://t.co/4tGcwkKdB5 #markets
May 18th 2019, 1:05am
dakotafinancial @dakotafinancial
Zacks Investment Research Lowers ChemoCentryx $CCXI to Hold https://t.co/JP93nHCXwn
May 17th 2019, 7:05pm
AmericanBanking @AmericanBanking
Zacks: Analysts Expect ChemoCentryx Inc $CCXI to Announce -$0.21 Earnings Per Share https://t.co/VYAXc5mI6G #stocks
May 17th 2019, 12:05pm
TranscriptDaily @TranscriptDaily
ChemoCentryx $CCXI Upgraded to Buy at Zacks Investment Research https://t.co/l1dxp85Xzv
May 17th 2019, 8:05am
AmericanBanking @AmericanBanking
B. Riley Comments on ChemoCentryx Inc’s Q2 2019 Earnings $CCXI https://t.co/wJzOxi27na #stocks
May 17th 2019, 6:05am
SwingTradeBot @SwingTradeBot
Rose Above 50 DMA today: $PFIN $CCXI ... https://t.co/qwiJH6vr1O
May 16th 2019, 2:05pm
ConsumerFeed @ConsumerFeed
ChemoCentryx $CCXI Upgraded by Zacks Investment Research to Buy https://t.co/oHnvh0kp3c
May 16th 2019, 1:05pm
AmericanBanking @AmericanBanking
FY2023 Earnings Estimate for ChemoCentryx Inc $CCXI Issued By B. Riley https://t.co/gecpyiGSQA #stocks
May 16th 2019, 9:05am
WeekHerald @WeekHerald
ChemoCentryx $CCXI Upgraded by Zacks Investment Research to Buy https://t.co/qsv0xP9nQv
May 15th 2019, 8:05pm
bulletin_en @bulletin_en
Baker Bros Advisors LP Has Lowered Stake in Chemocentryx $CCXI by $2.07 Million; Springbok Capital Management Has… https://t.co/DOb7iBlwxk
May 14th 2019, 12:05pm
happyycamperr @happyycamperr
@jsksrs $CCXI also conducting HS trials
May 14th 2019, 5:05am
bulletin_en @bulletin_en
Contrasting of Jaguar Health Inc. $CCXI https://t.co/1TE4PQ2YY1
May 13th 2019, 6:05pm
bulletin_en @bulletin_en
CytRx Corporation $CCXI Contrasting side by side https://t.co/cU2pTkhuno
May 13th 2019, 5:05pm
DataTrials @DataTrials
$CCXI Phase 3 A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis… Estimated… https://t.co/wbYT5X6QXF
May 13th 2019, 4:05pm
DataTrials @DataTrials
$CCXI Phase 2 A Study of CCX140-B in Subjects With FSGS… Estimated Primary Completion Date - 06/2019
May 13th 2019, 4:05pm
bbnsnews @bbnsnews
ChemoCentryx $CCXI Receives Buy Rating from HC Wainwright https://t.co/xvUiBah32O
May 11th 2019, 9:05am
ZolmaxNews @ZolmaxNews
Piper Jaffray Companies Equities Analysts Increase Earnings Estimates for ChemoCentryx Inc $CCXI https://t.co/jj2X0HwzjC
May 11th 2019, 3:05am
Allstocknews @Allstocknews
$CCXI New Form SC 13G/A for ChemoCentryx, Inc. From our Stock News Alerts App
May 10th 2019, 1:05pm
bulletin_en @bulletin_en
Immuron Limited $CCXI Contrasting side by side https://t.co/rj0Ot8XONq
May 10th 2019, 11:05am
WeekHerald @WeekHerald
Q2 2019 EPS Estimates for ChemoCentryx Inc $CCXI Lifted by Analyst https://t.co/ZC48XNkUN4
May 10th 2019, 2:05am
NewsToDesk @NewsToDesk
$CCXI $MOD: Hedge Funds Have Never Been More Bullish On ChemoCentryx Inc …: https://t.co/m6w6tCXCDi
May 9th 2019, 11:05am
AmericanBanking @AmericanBanking
Q2 2019 Earnings Estimate for ChemoCentryx Inc Issued By Piper Jaffray Companies $CCXI https://t.co/xWUOY8M7gL #stocks
May 9th 2019, 8:05am
ThisLincolnian @ThisLincolnian
Q2 2019 Earnings Estimate for ChemoCentryx Inc Issued By Piper Jaffray Companies $CCXI https://t.co/cSRVotsSBk
May 9th 2019, 8:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.